Synthetic mRNA for ex vivo therapeutic applications.

Hideyuki Nakanishi, Keiji Itaka
Author Information
  1. Hideyuki Nakanishi: Department of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.
  2. Keiji Itaka: Department of Biofunction Research, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan. Electronic address: itaka.bif@tmd.ac.jp.

Abstract

Synthetic mRNA is attracting much attention as a new drug modality. Now, there is great interest in the next applications of mRNA medicines, especially for therapeutic purposes of various diseases. Not only in vivo applicable mRNA medicines, there are many researches using ex vivo or in vitro mRNA transfection, some of which are already used in the preclinical or clinical settings. In this short article, the ex vivo mRNA applications are reviewed, in the hope of providing insight to develop future mRNA medicines.

Keywords

MeSH Term

RNA, Messenger
Transfection

Chemicals

RNA, Messenger

Word Cloud

Created with Highcharts 10.0.0mRNAapplicationsmedicinesex vivoSynthetictherapeuticattractingmuchattentionnewdrugmodalityNowgreatinterestnextespeciallypurposesvariousdiseasesin vivoapplicablemanyresearchesusingin vitrotransfectionalreadyusedpreclinicalclinicalsettingsshortarticlereviewedhopeprovidinginsightdevelopfutureCellengineeringGenomeeditingMessengerRNAReprogrammingmedicine

Similar Articles

Cited By